ENTITY

Ranbaxy Laboratories (RBXY IN)

11
Analysis
Health Care • India
Ranbaxy Laboratories Limited manufactures and distributes a wide range of pharmaceutical products. The Company makes multisource antibiotics, analgesics, anti-inflammatory drugs and anti-ulcerant/gastrointestinal drugs such as "Roscillin" (Ampicillin), "Cifran" (Ciprofloxacin) and "Sporidex" (Cephalexin).
more
bullish•Ipca Laboratories
•13 Apr 2018 15:14

IPCA Labs- The Revival Story

Ipca Laboratories Ltd (IPCA IN) is a fully integrated Indian pharmaceutical company. In FY17 45% of its revenues came from Indian dosage business,...

Share
•28 Jan 2017 19:36

HealthCare Global Enterprises (HCG)- A Niche Play in Burgeoning Indian Healthcare Sector

HealthCare Global Enterprises Limited (HCG IN) is a speciality healthcare provider with a focus on cancer and infertility treatment. It is the...

•12 Jan 2017 14:54

IPO Pipeline to Remain Strong as PE Funds, Quasi-Govt Promoters Aim for Portfolio Exits

Primary issuances are expected to remain strong in 2017 following a five-year high in funds raised in 2016 (Rs 220bn) even as Fed rate expectations...

Logo
1.3k Views
Share
•08 Dec 2016 08:24

MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry

Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...

Logo
4.1k Views
Share
•22 Nov 2015 13:18

Profit from India's Rapidly Growing Biotechnology Industry

Now is a strategic time to focus on the upside potential of biotechnology companies in India, as India’s biotechnology industry is projected to...

Share
x